Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 29, 2017
Autologous/Allogeneic Hematopoietic Cell Transplantation versus Tandem Autologous Transplantation for Multiple Myeloma: Comparison of Long-Term Postrelapse SurvivalMyo Htut, Anita D'Souza, Amrita Krishnan, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 10, 2022
Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 StudyAdam D Cohen, Parameswaran Hari, Myo Htut, et al.
Blood|June 3, 2026
Arlocabtagene autoleucel-a GPRC5D-targeted CAR T-cell therapy in heavily pretreated relapsed/refractory multiple myelomaSusan Bal, Myo Htut, Omar Nadeem, et al.
Seminars in Hematology|September 26, 2024
Mobilizing CARs: Benefits, drawbacks, and directions for outpatient CAR T-cell therapyJennifer S Woo, Kim Nguyen, Lawrence Liu, et al.
Physics in Medicine and Biology|January 20, 2021
Double-strand breaks measured along a 160 MeV proton Bragg curve using a novel FIESTA-DNA probe in a cell-free environmentKristen A McConnell, Chang Chang, Annelise Giebeler, et al.
Hepatology (Baltimore, Md.)|April 5, 2014
Liver transplantation in the management of porphyriaAshwani K Singal, Charles Parker, Christine Bowden, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|October 2, 2014
Placenta growth factor induces invasion and activates p70 during rapamycin treatment in trophoblast cellsAllison Knuth, Lawrence Liu, Halden Nielsen, et al.
The Lancet. Haematology|October 10, 2022
Health-related quality of life in patients given ciltacabtagene autoleucel for relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b-2, open-label studyThomas Martin, Yi Lin, Mounzer Agha, et al.
Seminars in Liver Disease|May 3, 2008
Cholestatic liver injury associated with whey protein and creatine supplementsKerry N Whitt, Stephen C Ward, Kemal Deniz, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 22, 2016
Prognostic impact of total and tyrosine phosphorylated GIV/Girdin in breast cancersYing Dunkel, Kexin Diao, Nicolas Aznar, et al.
Pageof 9